Edition:
United States

Protagonist Therapeutics Inc (PTGX.OQ)

PTGX.OQ on NASDAQ Stock Exchange Global Market

17.46USD
23 Feb 2018
Change (% chg)

$0.57 (+3.37%)
Prev Close
$16.89
Open
$17.09
Day's High
$17.62
Day's Low
$16.74
Volume
20,976
Avg. Vol
43,188
52-wk High
$23.36
52-wk Low
$8.00

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 8.78 -0.285
Jun '17 0.00 -0.888
Mar '17 0.00 -0.841
FY 2016 Dec '16 0.00 -0.767
Sep '16 0.00 -0.503
Jun '16 0.00 -0.500
Mar '16 0.00 -0.804
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 1 8.80 8.80 8.80 --
Quarter Ending Jun-18 1 8.50 8.50 8.50 --
Year Ending Dec-18 5 40.83 86.22 20.00 66.67
Earnings (per share)
Quarter Ending Mar-18 2 -0.37 -0.35 -0.39 --
Quarter Ending Jun-18 2 -0.38 -0.36 -0.39 --
Year Ending Dec-18 5 -1.29 0.66 -2.03 0.41
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 195.87 33.62
P/E High - Last 5 Yrs. -- 285.81 46.17
P/E Low - Last 5 Yrs. -- 93.64 24.19
Beta -- 0.81 0.81
Price to Sales (TTM) 40.62 137.83 8.35
Price to Book (MRQ) 5.12 20.52 5.22
Price to Tangible Book (MRQ) 6.17 28.04 6.44
Price to Cash Flow (TTM) -- 128.31 25.88
% Owned Institutions 92.34 11.86 2.30

Dividends

  Company industry sector
Dividend Yield -- 0.28 1.52
Dividend Yield - 5 Year Avg -- 0.20 2.01
Dividend 5 Year Growth Rate -- 1.85 5.23
Payout Ratio(TTM) -- 8.14 41.36

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 64.95 9.76
Sales (TTM) vs TTM 1 Yr. Ago -- 58.16 7.57
Sales - 5 Yr. Growth Rate -- 33.63 10.22
EPS (MRQ) vs Qtr. 1 Yr. Ago 43.31 -94.99 16.24
EPS (TTM) vs TTM 1 Yr. Ago -27.33 -- --
EPS - 5 Yr. Growth Rate -- 46.89 11.55
Capital Spending - 5 Yr. Growth Rate -- 43.77 14.75

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.65 2.42
Current Ratio (MRQ) 1.87 6.12 3.39
LT Debt to Equity (MRQ) 0.00 16.21 12.39
Total Debt to Equity (MRQ) 0.00 18.27 15.84
Interest Coverage (TTM) -5.13 -156.52 38.46

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 46.30 54.79
Gross Margin - 5 Yr. Avg. -- 55.30 52.59
EBITD Margin (TTM) -517.22 -- --
EBITD - 5 Yr. Avg -- -230.69 14.70
Operating Margin (TTM) -521.36 -487.70 4.10
Operating Margin - 5 Yr. Avg. -- -247.29 9.99
Pre-Tax Margin (TTM) -514.21 -463.92 4.83
Pre-Tax Margin - 5 Yr. Avg. -- -253.91 10.24
Net Profit Margin (TTM) -514.21 -445.10 1.55
Net Profit Margin - 5 Yr. Avg. -- -257.36 6.54
Effective Tax Rate (TTM) -- 0.46 21.93
Effective Tax Rate - 5 Yr. Avg. -- 17.72 24.14

Efficiency

  Company industry sector
Revenue/Employee (TTM) 250,886 23,863,557 817,554,851
Net Income/Employee (TTM) -1,290,086 -520,338 95,586,843
Receivable Turnover (TTM) 5.24 13.83 5.44
Inventory Turnover (TTM) -- 2.38 3.52
Asset Turnover (TTM) 0.08 0.39 0.90

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -42.35 -1.04 10.73
Return on Assets - 5 Yr. Avg. -- -0.14 12.03
Return on Investment (TTM) -58.01 -0.71 13.63
Return on Investment - 5 Yr. Avg. -- 2.18 15.76
Return on Equity (TTM) -58.14 -3.37 15.39
Return on Equity - 5 Yr. Avg. -- -1.91 17.03
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -152.70 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Protagonist Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 92.34%
# of Holders: 103
Total Shares Held: 18,911,085
3 Mo. Net Change: 3,902,717
# New Positions: 35
# Closed Positions: 5
# Increased Positions: 75
# Reduced Positions: 14
# Net Buyers: 61
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.